An expert panel consisting of dietitians, doctors, nutritional epidemiologists, chefs, and weight loss researchers examined ...

(HealthDay News) — Vaccines to protect against respiratory syncytial virus (RSV) in newborns and older adults are being more ...

Significant reductions seen in birth weight with exposure to certain DMTs, and increase seen in rate of small for gestational age ...

The FDA is expected to decide on treatments for Parkinson disease, PTSD and NF1-associated plexiform neurofibromas, in addition to 2 new vaccines.

(HealthDay News) — Racial and ethnic disparities are seen in the use of obesity management medications, according to a study published online Dec. 17 in the Journal of Racial and Ethnic Health ...

Navacaprant is an highly selective kappa opioid receptor antagonist expected to modulate reward processing pathways and mediate depressive states.

The approval of Opdivo Qvantig was supported by data from the randomized, open-label phase 3 CheckMate-67T study.

The Company has been granted Competitive Generic Therapy designation, which allows for 180 days of marketing exclusivity.

Norethindrone acetate 1mg, ethinyl estradiol 20mcg (21 tabs). 28-day products: 1 tab daily for 28 days; repeat. 21-day products: 1 tab daily for 21 days, then 7 tablet-free days; repeat.

Oxymetazoline HCl 0.05%; nasal spray. Local effects (eg, burning, stinging, sneezing, increased nasal discharge).

Psyllium husk 3.4g; per packet or rounded teaspoon; pwd; sugar-free; orange (contains phenyalanine) or unflavored; contains sodium, potassium. 3.4g of powder in 8oz liquid, or 2 wafers or 5 caps ...

Simethicone 62.5mg; per strip; peppermint-, cinnamon-flavors.